Pai noted that other studies in North America and Europe have shown that surpassed the interferon-gamma test the skin test. It is important to keep both tests on the menu so that health professionals can choose what works best for their target audience, said Pai. For high – burden, low-resource countries such as India, the skin test might have value. .
The results of the study, the eighth in a special June special issue on tuberculosis in the Journal of the American Medical Association published, mean that the transition to the more expensive blood test may not be necessary for the people of India. – ‘Our study is the first time blood test was evaluated in India, where TB is endemic high,’said Dr. Madhukar Pai, a postdoctoral fellow in epidemiology at UC Berkeley School of Public Health and lead author of the paper. ‘It is also the largest study of its kind among the health care workers, a group that is at high risk for occupational TB. ‘. Continue reading